Stay updated on Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial

Sign up to get notified when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page

  1. Check
    2 days ago
    No Change Detected
  2. Check
    9 days ago
    Change Detected
    Summary
    Revision tag updated to v3.3.4, replacing v3.3.3; no changes to the study details, eligibility criteria, or outcomes.
    Difference
    0.1%
    Check dated 2026-01-14T02:24:19.000Z thumbnail image
  3. Check
    16 days ago
    No Change Detected
  4. Check
    30 days ago
    Change Detected
    Summary
    Added a Locations section with a California site for the study; page revision updated to v3.3.3.
    Difference
    0.2%
    Check dated 2025-12-23T12:46:37.000Z thumbnail image
  5. Check
    52 days ago
    Change Detected
    Summary
    Footer revision tag updated from v3.3.1 to v3.3.2; no other visible content changes are evident. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-12-01T17:39:44.000Z thumbnail image
  6. Check
    59 days ago
    Change Detected
    Summary
    Site revision updated from v3.2.0 to v3.3.1; no impact on study details or page content. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.1%
    Check dated 2025-11-24T14:45:33.000Z thumbnail image
  7. Check
    67 days ago
    Change Detected
    Summary
    The government funding/status notice on the page was removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2025-11-17T07:16:19.000Z thumbnail image
  8. Check
    81 days ago
    Change Detected
    Summary
    Non-significant changes observed: the page shows a new last update date (2025-06-26) and minor layout/text adjustments, with no changes to study design, eligibility criteria, endpoints, or enrollment. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.5%
    Check dated 2025-11-03T01:22:23.000Z thumbnail image

Stay in the know with updates to Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Mocetinostat and Vinorelbine in Rhabdomyosarcoma Clinical Trial page.